Targeted Deletion of Btg1 and Btg2 Results in Homeotic Transformation of the Axial Skeleton

Por Tijchon, Esther, van Ingen Schenau, Dorette, van Opzeeland, Fred, Tirone, Felice, Hoogerbrugge, Peter M., Van Leeuwen, Frank N., Scheijen, Blanca
Publicado no PLoS One (2015)

Tumor suppressors BTG1 and BTG2 regulate early mouse B-cell development

Por Tijchon, Esther, van Emst, Liesbeth, Yuniati, Laurensia, van Ingen Schenau, Dorette, Havinga, Jørn, Rouault, Jean-Pierre, Hoogerbrugge, Peter M., van Leeuwen, Frank N., Scheijen, Blanca
Publicado no Haematologica (2016)

Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress

Por Yuniati, Laurensia, van der Meer, Laurens T., Tijchon, Esther, van Ingen Schenau, Dorette, van Emst, Liesbeth, Levers, Marloes, Palit, Sander A.L., Rodenbach, Caroline, Poelmans, Geert, Hoogerbrugge, Peter M., Shan, Jixiu, Kilberg, Michael S., Scheijen, Blanca, van Leeuwen, Frank N.
Publicado no Oncotarget (2015)

Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients

Por Scheijen, Blanca, Boer, Judith M., Marke, René, Tijchon, Esther, van Ingen Schenau, Dorette, Waanders, Esmé, van Emst, Liesbeth, van der Meer, Laurens T., Pieters, Rob, Escherich, Gabriele, Horstmann, Martin A., Sonneveld, Edwin, Venn, Nicola, Sutton, Rosemary, Dalla-Pozza, Luciano, Kuiper, Roland P., Hoogerbrugge, Peter M., den Boer, Monique L., van Leeuwen, Frank N.
Publicado no Haematologica (2017)